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ABSTRACT

The skeletal muscle of obese individuals exhibits a depressed ability to
metabolize fats. Exercise training is thought to rescue this dampened ability to
metabolize fats; mediated by a coordinated increase in the expression of a network of
genes that regulate metabolism and fuel utilization. The purpose of this study is to
determine the exercise-induced regulation of metabolically important genes in lean and
obese individuals. Muscle biopsies (one pre-exercise/baseline and one immediately postexercise) were obtained from 4 lean (BF% 24.4 ± 5.5; 23.5 yrs ± 1.9) and 13 obese (BF%
39.7 ± 2.4; 26.1 yrs ± 2.3), age-matched, relatively young subjects, free from overt
disease, non-smokers, and not taking medications known to alter metabolism. RNA was
isolated, quantified, reverse transcribed into cDNA, and evaluated using RT-PCR. The
pre-exercise mRNA content of pyruvate dehydrogenase kinase 4 (PDK4) was
significantly higher in the obese compared to the lean (P=0.04) and the mRNA content of
peroxisome proliferator-activated receptor alpha (PPARα) was significantly lower
(P=0.03). There were no differences in the mRNA content post-exercise. This suggests
exercise tends to improve the expression of important metabolic genes in the skeletal
muscle of the obese.
Keywords: skeletal muscle, metabolism, exercise, PPARs, PDK4, obese
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CHAPTER 1

INTRODUCTION

Obesity: Definition and Prevalence
In the United States, approximately 35 percent of adults and 17 percent of
children are considered obese—defined as a body mass index (BMI) greater than 30
kg/m2 (Ogden, Carroll, Kit, & Flegal, 2014; Smith & Smith, 2016). Obesity is referred to
as an imbalance of caloric intake and outflow thought to be the result of a combination of
environmental, economic, genetic, and individual factors (Smith & Smith, 2016). As a
result, research interests have focused on interventions, such as change in diet or physical
activity, to alter these factors across a population (Flegal KM, Carroll MD, Ogden CL, &
Johnson CL, 2002).
In a clinical environment, obesity denotes excess adiposity rather than excess
weight (Krebs, Jacobson, & American Academy of Pediatrics Committee on Nutrition,
2003). Visceral adipose tissue is known to be strongly correlated with increased risk of
cardiovascular disease (Bouchi et al., 2016; Fox et al., 2007). However, body
composition is predominantly defined by BMI, which utilizes body weight (usually in
kilograms) and height (usually in meters) to quantify an individual’s body composition
and place them into categories of obese and lean based on age and sex (Etchison et al.,
2011). BMI only takes into consideration relative body weight and does not consider
1

overall body composition such as body fat or muscle mass (Etchison et al., 2011).
Therefore, a more accurate method of defining body composition is by assessing body fat
percentage. Using dual energy X-ray absorptiometry (DXA), body composition is
determined by measuring an individual’s fat distribution based on density as well as
overall and regional body fat estimates (Pierce, 2014; Yang & Chang, 2016).
Obesity and Metabolic Health
Obesity tends to be strongly correlated to the development of insulin resistance,
metabolic syndrome, type 2 diabetes mellitus, and hypertension (Flegal KM et al., 2002).
Individuals who are severely obese tend to show altered fatty acid oxidation (FAO) levels
during fasting and decreased metabolic flexibility in response to insulin in skeletal
muscle tissue (Chomentowski, Coen, Radiková, Goodpaster, & Toledo, 2011).
Metabolic flexibility is a term used to refer to an organism’s ability to alter energy
oxidation to energy availability (Galgani, Moro, & Ravussin, 2008). More specifically it
refers to a switch from increased lipid oxidation and high uptake of fatty acids during
fasting to decreased lipid oxidation and high uptake of glucose in the presence of insulin
(Kelley & Mandarino, 2000). Obese individuals with altered metabolic flexibility also
tend to have increased insulin resistance, although the physiology behind this correlation
is unclear (Chomentowski et al., 2011).
The mitochondria serves as the source of oxidative energy in eukaryotic cells
(Heilbronn, Gan, Turner, Campbell, & Chisholm, 2007). The numerous mitochondria in
human skeletal muscle allow for ample fatty acid oxidation (Chomentowski et al., 2011).
However, the skeletal muscle of obese individuals tends to demonstrate a diminished
2

mitochondrial capacity (Chomentowski et al., 2011). In order to understand this
diminished capacity, research is concentrating on mitochondrial biogenesis (Heilbronn et
al., 2007). Mitochondrial biogenesis, which is the process of developing new
mitochondria in the cells, is mediated by both nuclear and mitochondrial encoded
genomes (Heilbronn et al., 2007). The genomes operate in coordination with one another
to produce numerous proteins involved in the uptake, transport, and oxidation of fatty
acids not only during rest, but also during muscular activity (Civitarese, Hesselink,
Russell, Ravussin, & Schrauwen, 2005).
Exercise and Metabolic Health
Research has shown the positive effects exercise has on the entire human body in
terms of metabolism and energy expenditure (Catoire et al., 2012). Exercise has been
shown to reduce cardiovascular disease, type 2 diabetes mellitus, and metabolic
syndrome (Gaesser, 2007; Kodama et al., 2009; LaMonte, Blair, & Church, 2005). In the
skeletal muscle, specifically, exercise increases cellular demands for oxygen, ATP,
glucose, and fatty acids (Catoire et al., 2012). This is accompanied by changes in
enzymatic activity and an increased capacity for FAO as a result of changes in gene
expression (Catoire et al., 2012; Tunstall et al., 2002). Aerobic exercise training is
known to alter expression of mRNA coding for important metabolic proteins and increase
mitochondrial enzyme activity as well as increase expression of nuclear-encoded genes
responsible for regulation of mitochondrial transcription in lean individuals (Egan,
O’Connor, Zierath, & O’Gorman, 2013; Heilbronn et al., 2007). Genes demonstrating
increased expression include peroxisome proliferator-activated receptor gamma
3

coactivator-1 alpha (PGC-1α) and mitochondrial transcription factor A (TFAM)
(Heilbronn et al., 2007).
However, the overall molecular mechanisms are complex and much is still
unknown in regards to the transcription and expression of many of the genes encoding for
proteins involved in increased FAO post-exercise training (Civitarese et al., 2005;
Tunstall et al., 2002). The specific effects of exercise training in obese individuals are
still under investigation. Researchers are working to determine the extent to which
exercise can reverse metabolic inflexibility and insulin resistance in the skeletal muscle
of these obese individuals (Heilbronn et al., 2007).
Critical Metabolic Genes
As mentioned above, PGC-1α is one of the critical genes involved in
mitochondrial activity (Heilbronn et al., 2007). This gene is expressed in a variety of
human tissue types including brown adipose tissue and skeletal muscle, both of which are
high in mitochondrial density (J. Lin et al., 2002). Multiple studies have found PGC-1α
to play a role in conditions such as obesity, diabetes mellitus, neuropathy, and
cardiomyopathy (J. D. Lin, Handschin, & Spiegelman, 2005).
Specifically, PGC-1α is a transcriptional coactivator vital to the coordination of
mitochondria biogenesis (Little, Safdar, Cermak, Tarnopolsky, & Gibala, 2010).
Research has shown that exercise tends to cause a temporary increase in both PGC-1α
transcription and mRNA expression in human skeletal muscle up to two hours postexercise (Henriette Pilegaard, Saltin, & Neufer, 2003). Studies have demonstrated that
activation of PGC-1α appears to facilitate the initial increase in mitochondrial production
4

in response to exercise, while an increase in PGC-1α protein production aids in
sustaining the production process (Wright et al., 2007). PGC-1α works by interacting
with transcription factors bound to the promoter regions of target genes rather than
binding DNA directly (Henriette Pilegaard et al., 2003). Once activated in the cytosol of
the cell, PGC-1α moves to the nuclear membrane where it can interact with nuclear
respiratory factors, estrogen-related receptor alpha, and myocyte enhancer factor 2 (J. D.
Lin et al., 2005; Little et al., 2010).

Figure 1: PGC-1α transcriptional coactivation. This figure illustrates the interactions of the proteins that result
from transcription of the genes of interest. These proteins coactivate mitochondrial DNA transcription.

The induction of nuclear respiratory factor 1 (NRF-1) gene expression by PGC-1α
is believed to play a role in activation of mitochondrial biogenesis and cellular respiration
(Ventura-Clapier, Garnier, & Veksler, 2008). NRF-1 protein functions primarily as a
transcription regulator mediating nuclear and mitochondrial interactions by binding
directly to mitochondrial DNA (mtDNA) (Baar, 2004; Scarpulla, 2002). A study
conducted by Patti et al. (2003) demonstrated a correlation between decreased expression
of NRF-1-dependent genes and type 2 diabetes mellitus associated insulin resistance.
5

This has created interest in further exploration of the gene’s explicit function. In rat
skeletal muscle, NRF-1 mRNA expression was shown to increase following an acute bout
of exercise (Murakami, Shimomura, Yoshimura, Sokabe, & Fujitsuka, 1998). Combined
with the knowledge that exercise training increases the respiratory capacity of human
skeletal muscle, these findings make further investigation of NRF-1 expression
advantageous (Baar, 2004).
Another downstream target of PGC-1α is mitochondrial transcription factor A
(TFAM). The gene is encoded in the nucleus and the resultant protein is transported to
the mitochondria to carry out its function (Gordon, Rungi, Inagaki, & Hood, 2001). This
protein binds to mtDNA and plays a role in its protection and stabilization (Ichiseki et al.,
2015). TFAM binds to enhancers along the mtDNA strand that are upstream of promoter
sites (Kelly & Scarpulla, 2004). Expression of TFAM is regulated by PGC-1α via NRF-1
and NRF-2 (Finck & Kelly, 2006). In one study conducted by Short et al. (2003),
abundance of mRNA encoding PGC-1α, NRF-1, and TFAM was shown to increase in
response to exercise by 55, 15, and 85%, respectively, indicating these genes are
prominent regulators of FAO in response to exercise training.
Two other peroxisome proliferator-activated receptors, PPARα and PPARδ, also
play a role in FAO (Luquet et al., 2004). PPARs are activated by lipid ligands such as
prostaglandins and eicosanoids (Vega, Huss, & Kelly, 2000; Wagner & Wagner, 2010).
Once activated, PPARα binds with PGC-1α to regulate transcription of enzymes involved
in both FAO and the citric acid cycle including acyl coenzyme A (acyl-CoA)
dehydrogenase (Baar, 2004). PPARα is found in high levels in tissues with great
6

oxidative energy demands such as muscle and brown adipose tissues while PPARδ is
expressed abundantly in the skeletal muscle (Manio, Inoue, Fujitani, Matsumura, &
Fushiki, 2016; Vega et al., 2000). Less is known about the function of PPARδ, also
known as PPARβ, which is a ubiquitously expressed protein (Gilde et al., 2003).
Researchers have demonstrated a positive correlation between PPARδ expression and
increased FAO along with glucose uptake leading many to believe it could play a role in
the management of metabolic disorders (Manio et al., 2016).
Another downstream target of PGC-1α is pyruvate dehydrogenase kinase 4
(PDK4) (Wende, Huss, Schaeffer, Giguère, & Kelly, 2005). PDK4 is activated when
PGC-1α binds estrogen-related receptor (ERRα) (Wende et al., 2005). PDK4 is a
mitochondrial protein that upregulates FAO by inhibiting the pyruvate dehydrogenase
complex which increases glucose oxidation (Leem & Lee, 2016). In a study conducted
by Pilegaard, Ordway, Saltin, & Neufer (2000), transcription of the PDK4 gene was
shown to increase in response to exercise demonstrating a shift from glycolysis to FAO
following exercise training. This information makes this a gene of interest in further
understanding metabolic flexibility in obese individuals.
In summary, our research has demonstrated that obesity is a growing health
concern that tends to be correlated to the development of insulin resistance, metabolic
syndrome, type 2 diabetes mellitus, and hypertension (Flegal KM et al., 2002). Obese
individuals tend to show decreased fatty acid oxidation (FAO) during fasting and
decreased metabolic flexibility in skeletal muscle tissue (Chomentowski et al., 2011).
However, research has shown the positive effects exercise has on metabolism and energy
7

expenditure, specifically the effects of aerobic exercise training on mRNA expression and
increased mitochondrial enzyme activity as well as increased expression of nuclearencoded genes responsible for regulation of mitochondrial transcription in lean
individuals (Catoire et al., 2012; Egan et al., 2013; Heilbronn et al., 2007). However,
much is still unknown about the overall, complex mechanisms in regards to the
transcription and expression of many of the genes encoding for proteins involved in
increased FAO post-exercise training (Civitarese et al., 2005; Tunstall et al., 2002). The
purpose of the present study is to determine if an acute bout of moderate-intensity
exercise could favorably impact the expression of metabolically important genes in
skeletal muscle from obese individuals.
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CHAPTER 2

METHODS

This study involved the processing of samples previously collected at East
Caroline University (ECU) following approval by the ECU University and Medical
Center Institutional Review Board. Briefly, lean and obese subjects were briefed on all
study procedures and signed an informed consent prior to participation. Subjects
underwent a general health screening (BMI assessment, resting blood pressure and heart
rate, etc.) and completed a brief medical history questionnaire. Biological specimens
were collected at East Carolina University and skeletal muscle samples were processed at
Western Kentucky University (WKU) as part of this thesis project, upon receiving
approval from the WKU Biosafety Committee.

9

Figure 2: Study Workflow. This figure illustrates the overall methodology used to conduct the experiment.
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Subjects
Subject demographic and physical characteristics according to categorization by
BMI are provided in Table 1. Subjects included 8 lean (BMI 23.1 kg/m2 ± 0.7; 23.8 yrs ±
1.3) and 9 obese (34.2 kg/m2 ± 1.1; 27.0 yrs ± 3.2) adult humans. According to Pierce et
al. (2014), subjects were excluded if they did not fit within preferred BMI categories or
exercised more than 3 days per week. Participants included both men and women, who
were age-matched, relatively young, non-smokers that were not taking any medication
known to alter their metabolism or pregnant (Pierce, 2014).
Participants were also categorized according to body fat percentage (BF%) using
DXA values. When subjects were categorized as lean versus obese using BF%, 4 were
classified as lean (BF% 24.4 ± 5.5; 23.5 yrs ± 1.9) and 13 were classified as obese (BF%
39.7 ± 2.4; 26.1 yrs ± 2.3). Participant demographics and anthropometric data are
presented in Table 2 based on categorization by BF%.
Design
Briefly, subjects had height measured and weight assessed along with a dualenergy X-ray absorptiometry (DXA) scan (Prodigy, GE Lunar Corp., Madison, WI) prior
to the pre-exercise muscle biopsy (Pierce, 2014). Following the pre-exercise muscle
biopsy, participants wore a heart rate monitor and exercised at 60% of their heart rate
reserve (HRR), which approximated 60% of their VO2 max, for 60 minutes on a Monark
Ergomedic 828E cycle ergometer (See Figure 2) (Monark Exercise, AB, Sweden)
(Pierce, 2014). Resting serum levels of glucose and insulin were analyzed for basic
blood chemistries (Pierce, 2014).
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Muscle Biopsies
Approximately 100-150mg of skeletal muscle was obtained from the vastus
lateralis of subjects by a percutaneous muscle biopsy (See Figure 2). A 30-45mg sample
was immediately frozen in liquid nitrogen and stored at -80°C. An additional 30-45mg
sample was minced in RNAlater and also stored at -80°C. Two muscle biopsies were
performed on each subject: 1) pre-exercise/baseline and 2) immediately post-exercise.
RNA Isolation and Analysis
RNA was isolated for muscle samples using TRIzol® Reagent according to the
manufacturer’s protocol. Quantification of RNA samples was first determined using a
NanoDrop Spectrophotometer. 2μL of each sample was run in duplicate and a mean
value was calculated for concentration in ng/μL. The RNA samples were then quantified
again and also qualified using the Agilent 2100 Bioanalyzer and RNA 6000 Nano Assay
Kit (See Figure 2). The RNA Nano Chip was loaded with 1μL of each sample in
duplicate along with 5μL RNA Nano Marker. In addition, each chip contained two wells
of 9μL RNA Nano Gel-Dye Mix and 1μL RNA ladder. A mean concentration value was
calculated for concentration in ng/μL. RNA quality was measured using a mean RNA
Integrity Number (RIN).
RNA samples were reverse transcribed into cDNA using a High Capacity cDNA
Reverse Transcription Kit (See Figure 2). 2μL of buffer, 0.80μL of dNTP mix (100mM),
2μL of random primers, 1μL of MultiScribe Reverse Transcriptase, and Nuclease-free
H2O were added to the RNA samples for the reaction. After being briefly centrifuged,
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samples were placed in a thermal cycler under the following conditions: 10 minutes at
25°C, then 120 minutes at 37°C, then 5 minutes 85°C, and infinite hold at 4°C.
Real time polymerase chain reaction (RT-PCR) was used to evaluate the RNA
expression of PGC-1α and its five downstream targets (PPARδ, PPARα, NRF-1, TFAM,
PDK4). Optimization of the various genes was completed to determine optimal
concentrations for amplification to occur. The cDNA samples were multiplexed using
the endogenous control B2M. Samples were run in triplicate using TaqMan® Universal
PCR Master Mix at a 2X concentration, gene expression assays at 20X concentrations,
and Nuclease-free H2O. PCR was run using the following cycle profile: 95°C for 10
minutes × 1 for denaturation, 95°C for 15 seconds × 40 for annealing, and 60°C for 1
minute × 1 for extension. The threshold cycle (Ct value) was recorded for each gene of
interest for each sample (See Figure 2).
Statistical Analysis
Analysis of data between lean and obese demographics and metabolic gene
expression was assessed using a T-test for independent samples using SPSS statistical
software. Data is reported as mean ± SD and α-level was set a p≤ 0.05.
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CHAPTER 3

RESULTS
Participant’s Weight Status Classified by BMI
Subjects were categorized by BMI (lean: 23.1 kg/m2 ± 0.7 versus obese 34.2
kg/m2 ± 1.1, p<0.01). Anthropometric data are presented in Table 1. Difference in age
was insignificant (p=0.37). Differences in DXA (p=0.03), insulin levels (p<0.01), and
HOMA-IR (p<0.01) were all significant while difference in glucose levels (p=0.18) was
insignificant.
Table 1: Subject Demographics Based on Body Mass Index (BMI)
Lean (n=8)
Obese (n=9)
Male/Female
4/4
6/3
Age (years)
23.8 ± 1.3
27.0 ± 3.2
BMI (kg/m2)
23.1 ± 0.7
34.2 ± 1.1
DXA (Region % Fat)
30 ± 3.8
41.4 ± 2.8
Glucose (mg/dL)
84.3 ± 2.3
89.1 ± 2.5
Insulin (uIU/mL)
6.8 ± 1.1
15.9 ± 1.4
HOMA-IR
1.4 ± 0.2
3.5 ± 0.4
Values are mean ± SD; *P<0.05 vs Lean group

*
*
*
*

p-value
n/a
0.37
< 0.01
0.03
0.18
< 0.01
< 0.01

Table 1: Basic demographic information and anthropometric data for study participants when categorized by
BMI.

Participant’s Weight Status Classified by BF%
Subjects were also categorized by body fat percentage (BF%) based on DXAassessed body composition (lean 24.4 ± 5.5 versus obese 39.7 ± 2.4; p=0.01). Difference
is age was insignificant (p=0.56) and there was a good distribution of males and females
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(lean: 2/2 and obese: 8/5) in each group. However, the group numbers (lean: n=4 and
obese: n=13) were not equally distributed. BMI (p<0.01), Android (p=0.02), A/G ratio
(p=0.03), fasting insulin (p=0.03), and HOMA-IR (p=0.04) were significantly higher in
the obese subjects.
Table 2: Subject Demographics Based on Body Fat Percentage (BF%)
Lean (n=4)
Obese (n=13)
Male/Female
2/2
8/5
Age (years)
23.5 ± 1.9
26.1 ± 2.3
BMI (kg/m2)
22.0 ± 1.1
31.2 ± 1.5 *
DXA (Region % Fat)
24.4 ± 5.5
39.6 ± 2.4 *
Android (% Fat)
28.2 ± 5.6
50.7 ± 1.7 *
Gynoid (% Fat)
33.0 ± 7.5
44.0 ± 3.4
A/G Ratio
0.9 ± 0.1
1.2 ± 0.1 *
Glucose (mg/dL)
84.5 ± 4.5
87.5 ± 1.9
Insulin (uIU/mL)
6.2 ± 1.4
13.3 ± 1.5 *
HOMA-IR
1.3 ± 0.3
2.9 ± 0.4 *
Values are mean ± SD; *P<0.05 vs Lean group

p-value
n/a
0.56
< 0.01
0.01
0.02
0.15
0.03
0.57
0.03
0.04

Table 2: Subject demographics and anthropometric data based on categorization by body fat percentage (BF%).
HOMA-IR refers to a homeostatic model assessment for insulin resistance determined using glucose and insulin
values.

mRNA Analysis
To investigate potential differences in metabolic gene expression between lean
and obese individuals, that likely influence resting metabolism, mRNA content was
compared at baseline. Differences in baseline (pre-exercise) mRNA content between
lean and obese participants was assessed in two ways—1) based on BMI weight status
classification and 2) based on BF% weight status classifications. There were no
differences in the mRNA content of the genes of interest when groups were determined
by BF%, there was a difference in the pre-exercise mRNA content of peroxisome
proliferator-activated receptor alpha (PPARα), which was significantly lower (p=0.03) in
the obese compared to the lean (See Table 3 and Figure 3). Pre-exercise mRNA content
15

of pyruvate dehydrogenase kinase 4 (PDK4) was significantly higher in the obese
compared to the lean (p=0.04) (See Table 3 and Figure 4). All other mRNA content for
the other genes showed no difference pre-exercise. However, an acute bout of exercise
resulted in no differences in the expression of these genes (PPARα, PDK4) between lean
and obese individuals. There were no significant increases in mRNA content observed
immediately post-exercise for any of the genes analyzed.

Figure 3: Pre-exercise PPARα gene expression in lean and obese individuals categorized by BF%.
Expression was significantly higher in lean individuals as compared to obese individuals.
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Figure 4: Pre- and post-exercise PDK4 gene expression in lean and obese individuals categorized by
BF%. Pre-exercise expression was significantly higher in obese individuals as compared to lean
individuals. No significant difference was seen post-exercise.

Table 3: Gene Expression Pre- and Post-Exercise
Lean (n=4)
Male/Female
2/2
Age (years)
23.5 ± 1.9
DXA (Region % Fat)
24.4 ± 5.5
TFAM PreEx
0.21 ± 0.01
TFAM PostEx
0.11 ± 0.03
PDK4 PreEx
0.02 ± 0.01
PDK4 PostEx
0.18 ± 0.09
PGC-1α PreEx
0.07 ± 0.03
PGC-1α PostEx
0.11 ± 0.05
NRF-1 PreEx
0.10 ± 0.03
NRF-1 PostEx
0.10 ± 0.02
PPARδ PreEx
0.10 ± 0.02
PPARδ PostEx
0.08 ± 0.03
PPARα PreEx
0.15 ± 0.03
PPARα PostEx
0.14 ± 0.05
Values are mean ± SD; *P<0.05 vs Lean group

Obese (n=13)
8/5
26.1 ± 2.3
39.6 ± 2.4 *
0.11 ± 0.03
0.12 ± 0.03
0.07 ± 0.01 *
0.12 ± 0.03
0.09 ± 0.02
0.09 ± 0.03
0.10 ± 0.02
0.14 ± 0.03
0.11 ± 0.02
0.21 ± 0.08
0.08 ± 0.01 *
0.11 ± 0.02

p-value
n/a
0.56
0.01
0.18
0.82
0.04
0.41
0.71
0.73
0.95
0.50
1.00
0.34
0.03
0.60

Table 3: Difference in gene expression based on results from RT-PCR of reverse-transcribed cDNA from RNA
of subjects’ muscle biopsies. Significant differences were found in PDK4 expression pre-exercise and in PPARα
expression pre-exercise.
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CHAPTER 4

DISCUSSION

In the current study, exercise-induced differences in metabolic gene expression
were examined in lean and obese individuals. The primary findings of this study were
the following: 1) pre-exercise gene expression of pyruvate dehydrogenase kinase 4
(PDK4) was higher in obese compared to lean subjects and 2) pre-exercise gene
expression of peroxisome proliferator-activated receptor alpha (PPARα) was lower in
obese compared to lean subjects. These findings were observed when subjects were
categorized by body fat percentage (BF%). No differences in metabolic gene expression
were observed post-exercise. When subjects were categorized by body mass index
(BMI), no difference in metabolic gene expression was observed pre- or post-exercise.
The observed higher levels of gene expression of PDK4 in obese subjects
corresponded with findings from other studies. PDK4 is an enzyme known to inhibit the
pyruvate dehydrogenase complex that stimulates oxidation of glucose for energy use
(Leem & Lee, 2016). PDK4 thus inhibits the breakdown of stored glucose. Lower levels
of insulin along with increased levels of fatty acids promote PDK4 expression (Huang,
Wu, Bowker-Kinley, & Harris, 2002). This has been demonstrated in studies that show
increased expression of PDK4 in individuals with diabetes or insulin-resistance (Kwon,
Huang, Unterman, & Harris, 2004; Rosa et al., 2003). Another study demonstrated
18

upregulation of PDK4 following a high fat diet (Constantin-Teodosiu, Constantin,
Stephens, Laithwaite, & Greenhaff, 2012). However, another study in transgenic mice in
which the PDK4 gene had been deleted showed improved glucose metabolism (Tao,
Xiong, Harris, White, & Dong, 2013). In addition, a study conducted by Kwon et al.
(2004) demonstrated that insulin led to a decreased expression of PDK4 under normal
physiological conditions allowing for utilization of stored glucose for energy. These
studies in addition to the current study lead to the conclusion that the higher level of
baseline expression of PDK4 in obese individuals is related to insulin resistance.
Although fasting insulin levels were significantly higher in the obese subjects (13.3 ± 1.5
μIU/mL vs. 6.2 ± 1.4 μIU/mL; p=0.03), it did not result in decreased PDK4 expression.
The decreased levels of PPARα gene expression pre-exercise in obese subjects
from the current study correspond to findings of other studies. PPARα is expressed most
abundantly in tissues with high oxidative energy demands due to its role as a co-regulator
of transcription of enzymes involved in FAO (Baar, 2004; Manio et al., 2016; Vega et al.,
2000). In a study conducted by Costet et al. (1998), absence of this gene was shown to
be highly correlated to obesity. Additionally, studies have been conducted that show
decreased expression of PPARα to be positively correlated with reduced insulin
sensitivity, diabetic conditions, and adiposity (Chou et al., 2002; Fu et al., 2003; GuerreMillo et al., 2000; Kim et al., 2003). These findings in addition to the current study seem
to show a positive correlation between PPARα gene expression and improved metabolic
health.
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The insignificant differences observed in all other genes pre- and post-exercise
could be the result of several factors. This study was limited by the small sample size
(n=17) and by the uneven distribution of participants when categorized by BF% (lean:
n=4; obese: n=13). Another limit to the study was the time of muscle biopsy collection.
In order to maintain minimal discomfort for participants, only one biological specimen
was collected per subject immediately post-exercise. Collecting multiple muscle biopsies
at varying post-exercise time intervals would have allowed for a more comprehensive
examination of metabolic gene expression post-exercise.
In conclusion, the elevated levels of PDK4 in obese individuals pre-exercise are
consistent with findings in other studies that show elevated baseline expression with
higher insulin levels. The baseline differences (between lean and obese) in PPARα
expression appear to be consistent with a compromised metabolic function in obese
individuals that then seems to be abolished with an acute bout of exercise. These
findings indicate even a relatively mild, acute exercise stimulus may be helpful in
improving the metabolic health of obese individuals.
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